[go: up one dir, main page]

MC1983A1 - Composes heterocycliques,leur preparation et medicaments qui contiennent de tels composes - Google Patents

Composes heterocycliques,leur preparation et medicaments qui contiennent de tels composes

Info

Publication number
MC1983A1
MC1983A1 MC882012A MC2012A MC1983A1 MC 1983 A1 MC1983 A1 MC 1983A1 MC 882012 A MC882012 A MC 882012A MC 2012 A MC2012 A MC 2012A MC 1983 A1 MC1983 A1 MC 1983A1
Authority
MC
Monaco
Prior art keywords
formula
radical
compound
given
aryl
Prior art date
Application number
MC882012A
Other languages
English (en)
French (fr)
Inventor
Duncan Robertson Alan
Richard Martin Graeme
Susan Buckingham Janet
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1983A1 publication Critical patent/MC1983A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MC882012A 1987-10-23 1988-10-21 Composes heterocycliques,leur preparation et medicaments qui contiennent de tels composes MC1983A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878724912A GB8724912D0 (en) 1987-10-23 1987-10-23 Indole derivatives

Publications (1)

Publication Number Publication Date
MC1983A1 true MC1983A1 (fr) 1989-11-23

Family

ID=10625806

Family Applications (1)

Application Number Title Priority Date Filing Date
MC882012A MC1983A1 (fr) 1987-10-23 1988-10-21 Composes heterocycliques,leur preparation et medicaments qui contiennent de tels composes

Country Status (18)

Country Link
EP (1) EP0313397B1 (pt)
JP (1) JP2501631B2 (pt)
CN (1) CN1035113A (pt)
AT (1) ATE90089T1 (pt)
AU (1) AU604165B2 (pt)
DD (1) DD283140A5 (pt)
DE (1) DE3881472T2 (pt)
DK (1) DK586588A (pt)
ES (1) ES2054825T3 (pt)
FI (1) FI884879A7 (pt)
GB (1) GB8724912D0 (pt)
HU (1) HU202230B (pt)
IL (1) IL88122A0 (pt)
MC (1) MC1983A1 (pt)
NZ (1) NZ226671A (pt)
PL (1) PL158305B1 (pt)
PT (1) PT88829B (pt)
ZA (1) ZA887900B (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
DK0486666T3 (da) * 1990-06-07 1998-03-30 Zeneca Ltd Terapeutisk heterocykliske forbindelser
EP0494774A1 (en) * 1991-01-11 1992-07-15 MERCK SHARP & DOHME LTD. Indazole-substituted fivemembered heteroaromatic compounds
US5317103A (en) * 1991-01-15 1994-05-31 Merck Sharp & Dohme Limited Indole-substituted five-membered heteroaromatic compounds as 5-HT1 agonists
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW263508B (pt) * 1991-02-12 1995-11-21 Pfizer
GB9104136D0 (en) * 1991-02-27 1991-04-17 Merck Sharp & Dohme Therapeutic agents
BR9206810A (pt) * 1991-11-25 1995-10-31 Pfizer Derivados de indol
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
US5409941A (en) * 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (pt) * 1992-03-05 1996-10-11 Pfizer
US5510362A (en) * 1992-03-13 1996-04-23 Merck, Sharp And Dohme Limited Imidazole, triazole and tetrazole derivatives
GB9207396D0 (en) * 1992-04-03 1992-05-13 Merck Sharp & Dohme Therapeutic agents
US5747501A (en) 1992-04-07 1998-05-05 Pfizer, Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
ATE148465T1 (de) * 1992-04-10 1997-02-15 Pfizer Acylaminoindolderivate als 5-ht1 agonisten
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
GB9208463D0 (en) * 1992-04-16 1992-06-03 Merck Sharp & Dohme Therapeutic agents
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
KR100286411B1 (ko) * 1992-06-05 2001-04-16 더블유. 지. 콜 치환된 트리아졸의 설페이트 염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
GB9215526D0 (en) * 1992-07-22 1992-09-02 Merck Sharp & Dohme Chemical process
JPH07509452A (ja) * 1992-07-24 1995-10-19 メルク シヤープ エンド ドーム リミテツド イミダゾール,トリアゾール及びテトラゾール誘導体
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
TW251284B (pt) * 1992-11-02 1995-07-11 Pfizer
GB9226537D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
LT3594B (en) 1993-07-29 1995-12-27 Merck Sharp & Dohme Imidazole,triazole and tetrazole derivatives
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
US6423731B2 (en) 1994-01-06 2002-07-23 Zeneca Limited Indole derivatives as prodrugs of 5-HT1-like receptor agonists
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
GB9407447D0 (en) * 1994-04-14 1994-06-08 Glaxo Group Ltd Chemical compounds
EP0765322B1 (en) * 1994-06-01 2001-07-25 AstraZeneca AB Indole derivatives as prodrugs of 5-ht1-like receptor agonists
MX9700693A (es) * 1994-07-26 1997-04-30 Pfizer Derivados del 4-indol.
AU699281B2 (en) * 1994-12-06 1998-11-26 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists
US6909005B1 (en) 1995-08-07 2005-06-21 Astrazeneca Uk Limited One post synthesis of 2-oxazolidinone derivatives
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
GB9516143D0 (en) 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
US5998438A (en) * 1996-11-26 1999-12-07 Allelix Biopharmaceuticals, Inc. 5-cyclo indole compounds
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
WO2000000490A2 (en) * 1998-06-26 2000-01-06 Eli Lilly And Company 5-ht1f agonists
JP4455992B2 (ja) 2002-06-21 2010-04-21 スベン ライフ サイエンシズ リミティド 治療薬剤として有用なセロトニン受容体親和性を有するアリールアルキル・インドール、その製造方法、並びにそれらを含む医薬組成物
NZ537770A (en) 2002-06-21 2007-03-30 Suven Life Sciences Ltd Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
DK1581492T3 (da) 2002-11-28 2008-11-10 Suven Life Sciences Ltd N-arylsulfonyl-3-substituerede indoler med serotoninreceptoraffinitet, fremgangsmåde til fremstilling heraf og en farmaceutisk sammensætning indeholdende disse
EA009193B1 (ru) 2002-11-28 2007-12-28 Сувен Лайф Сайенсиз Лимитед N-арилсульфонил-3-аминоалкоксииндолы
EA009367B1 (ru) 2002-12-18 2007-12-28 Сувен Лайф Сайенсиз Лимитед ПРОИЗВОДНЫЕ 5-ТИА-5-ДИОКСО-4b-АЗАИНДЕНО[2,1-a]ИНДЕНА, ОБЛАДАЮЩИЕ АФФИННОСТЬЮ К РЕЦЕПТОРУ СЕРОТОНИНА
DE102005018191A1 (de) 2005-04-19 2006-10-26 Grünenthal GmbH Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
BR112018015367A2 (pt) 2016-01-27 2018-12-18 Instar Tech A S carreadores oromucosais de nanofibra para tratamento terapêutico
CN112759550A (zh) * 2019-11-04 2021-05-07 上海科技大学 一种平滑受体拮抗剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833153A (en) 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB8600397D0 (en) 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
IL88122A0 (en) 1989-06-30
GB8724912D0 (en) 1987-11-25
PT88829B (pt) 1993-01-29
PL275423A1 (en) 1989-08-07
NZ226671A (en) 1991-09-25
ES2054825T3 (es) 1994-08-16
DD283140A5 (de) 1990-10-03
JP2501631B2 (ja) 1996-05-29
FI884879A0 (fi) 1988-10-21
HUT50163A (en) 1989-12-28
DK586588D0 (da) 1988-10-21
AU604165B2 (en) 1990-12-06
JPH01146882A (ja) 1989-06-08
PL158305B1 (en) 1992-08-31
EP0313397B1 (en) 1993-06-02
DE3881472D1 (de) 1993-07-08
CN1035113A (zh) 1989-08-30
AU2418188A (en) 1989-04-27
HU202230B (en) 1991-02-28
DE3881472T2 (de) 1993-12-16
ZA887900B (en) 1990-06-27
ATE90089T1 (de) 1993-06-15
DK586588A (da) 1989-04-24
FI884879A7 (fi) 1989-04-24
EP0313397A1 (en) 1989-04-26

Similar Documents

Publication Publication Date Title
MC1983A1 (fr) Composes heterocycliques,leur preparation et medicaments qui contiennent de tels composes
RU2160736C2 (ru) Производные индола и их физиологически приемлемые соли и сольваты, способы их получения, лекарственное средство для лечения или профилактики клинических состояний, для которых показан прием агониста "5-нт1-подобного" рецептора, и способ его получения
CH651550A5 (fr) Derives de l'indole, leur preparation et compositions pharmaceutiques les contenant.
FR2530625A1 (fr) Derives d'indole, procedes pour leur preparation et compositions pharmaceutiques les contenant
EP1255751A2 (fr) Derives de 1,3-dihydro-2h-indol-2-one et leur utilisation en tant que ligands des recepteurs v1b ou v1b et v1a de l'arginine-vasopressine
FR2555987A1 (fr) Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation
WO1995018105A1 (fr) Derives de 1,3-dihydroindol-2-one substitues en 3 par un groupe azote comme agonistes et/ou antagonistes de la vasopressine et/ou de l'ocytocine
WO1997000860A1 (fr) Composes agonistes du recepteur cb¿2?
FR2488607A1 (fr) Derives de l'indole, leur preparation et leurs utilisations pharmaceutiques
CH652394A5 (fr) Derives indoliques, leur preparation et medicaments les renfermant.
FR2722190A1 (fr) Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
JPH09512248A (ja) 5−ht▲下1▼作動薬としてのインドール誘導体
FR2574793A1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
JP2669765B2 (ja) (1h−インドール−1−イル)−2−(アミノ)アセトアミドおよび関連した(1h−インドール−1−イル)−(アミノアルキル)アミド、中間体およびそれらの製法ならびにそれらを含有する神経保護剤
JPH09510706A (ja) ドパミン作動性活性を有するベンゾイミダゾール誘導体
CH671017A5 (pt)
CA2301750A1 (fr) Derives d'indole comme agonistes de 5-ht1b et 5-ht1d
JPH09506083A (ja) フエニルインドール化合物
FR2600061A1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
US5225431A (en) Therapeutic substituted indole compounds and compositions thereof
TW200526651A (en) 3-substituted β-lactamyl vasopressin V1a antagonists
FR2462436A1 (fr) Nouvelles 2-(5-pyrazolylamino)-2-imidazolines, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
YP Annual fee paid